tiprankstipranks
Opus Genetics (IRD)
NASDAQ:IRD
US Market

Opus Genetics (IRD) Financial Statements

Compare
1,021 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently $34.73M. The company's EPS TTM is $-1.086; its P/E ratio is ―; Opus Genetics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 19.05M$ 39.85M$ 589.00K--
Operating Income$ -10.56M$ 18.23M$ -22.70M$ -19.97M$ -4.19M
EBITDA$ -9.97M$ 18.22M$ -56.69M$ -17.77M$ -3.64M
Net Income$ -9.99M$ 17.89M$ -56.69M$ -24.62M$ -6.17M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 53.95M$ 48.99M$ 26.08M$ 17.68M$ 1.78M
Total Debt$ 0.00$ 0.00$ 538.00K$ 0.00$ 5.73M
Net Debt$ -50.52M$ -42.68M$ -24.21M$ -16.40M$ 4.19M
Total Liabilities$ 4.04M$ 2.75M$ 3.85M$ 31.15M$ 9.34M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -1.11M$ 14.31M$ -19.37M$ -6.80M$ -3.62M
Operating Cash Flow$ -1.11M$ 14.31M$ -19.37M$ -6.80M$ -3.59M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Opus Genetics Earnings and Revenue History

Opus Genetics Debt to Assets

Opus Genetics Cash Flow

Opus Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis